Valuation: Teyi Pharmaceutical Group Co.,Ltd

Market Cap 4.72B 701M 602M 562M 515M 969M 67.03B 985M 6.63B 2.6B 33.62B 2.63B 2.58B 111B P/E 2024
224x
P/E 2025 67.8x
Enterprise Value 4.65B 691M 592M 553M 507M 954M 66B 970M 6.53B 2.56B 33.1B 2.59B 2.54B 109B EV / Sales 2024
6.57x
EV / Sales 2025 5.78x
Free-Float
60.48%
Yield 2024
0.56%
Yield 2025 1.38%
1 day-2.21%
1 week-0.43%
Current month+5.44%
1 month+0.76%
3 months-1.90%
6 months-24.25%
Current year-14.19%
1 week 9.16
Extreme 9.16
9.68
1 month 8.2
Extreme 8.2
9.68
Current year 7.66
Extreme 7.66
14.47
1 year 7.66
Extreme 7.66
15.21
3 years 6.79
Extreme 6.79
17.49
5 years 5.64
Extreme 5.642856
19.64
10 years 5.01
Extreme 5.010203
20.4
Manager TitleAgeSince
Chief Executive Officer 34 16/07/2025
Director of Finance/CFO 54 15/06/2009
Corporate Officer/Principal 43 01/06/2020
Director TitleAgeSince
Director/Board Member 54 15/06/2009
Director/Board Member 43 27/06/2022
Chairman 34 16/07/2025
Date Insider Type Main position Quantity % Market Cap.
2/7/24 A Buy

Chief Financial Officer

42,000 0.0188%
6/14/23 A Buy

Chief Financial Officer

42,000 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%-0.43%-0.53%-15.58% 691M
-1.64%+4.72%+79.47%+130.18% 1,141B
-0.82%+3.63%+51.87%+62.30% 659B
-0.30%+5.79%+26.87%+76.71% 470B
+0.59%+1.90%+40.70%+45.18% 366B
-0.57%+2.20%+23.54%+40.51% 302B
-0.69%+2.15%-0.13%+12.05% 254B
-1.54%+4.41%+47.17%+67.35% 239B
-0.77%-0.03%-13.73%-52.72% 207B
-1.93%+5.13%+22.32%+91.24% 183B
Average -0.92%+3.50%+27.75%+45.72% 382.17B
Weighted average by Cap. -0.82%+4.31%+45.01%+73.11%

Financials

2024 2025
Net sales 688M 102M 87.64M 81.84M 75.08M 141M 9.77B 144M 966M 378M 4.9B 384M 375M 16.19B 925M 137M 118M 110M 101M 190M 13.13B 193M 1.3B 508M 6.58B 516M 504M 21.77B
Net income 20.5M 3.04M 2.61M 2.44M 2.24M 4.21M 291M 4.28M 28.78M 11.27M 146M 11.43M 11.18M 483M 81.67M 12.13M 10.41M 9.72M 8.92M 16.77M 1.16B 17.04M 115M 44.9M 582M 45.55M 44.56M 1.92B
Net Debt 58.68M 8.72M 7.48M 6.98M 6.41M 12.05M 833M 12.24M 82.39M 32.26M 418M 32.73M 32.02M 1.38B -72.61M -10.79M -9.25M -8.64M -7.93M -14.91M -1.03B -15.15M -102M -39.92M -517M -40.5M -39.62M -1.71B
Logo Teyi Pharmaceutical Group Co.,Ltd
Teyi Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of traditional Chinese medicine preparations, chemical pharmaceutical preparations, and chemical raw materials. The Company's products cover respiratory system, cardiovascular system, digestive system, dermatology, pediatrics, tonics, hypoglycemic agents, and wind-dispelling and dampness-removing agents. The Company's main products include Zhikebao Pian, Ganmaoling Keli, Yinxingye Fensanpian, Yixinshu Keli, Hydrotalcite Chewable Tablets, Omeprazole Enteric Capsules and others. The Company primarily conducts its businesses in domestic market.
Employees
1,434
Date Price Change Volume
19/08/26 CN¥9.310 -2.21% 15,556,540
18/08/26 CN¥9.520 -0.42% 16,395,904
17/08/26 CN¥9.560 +1.70% 21,669,328
14/08/26 CN¥9.400 -0.95% 19,269,632
13/08/26 CN¥9.490 +1.50% 30,607,036

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002728 Stock